These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 18787978)
1. Candida albicans and Candida tropicalis in oral candidosis: quantitative analysis, exoenzyme activity, and antifungal drug sensitivity. da Costa KR; Ferreira JC; Komesu MC; Candido RC Mycopathologia; 2009 Feb; 167(2):73-9. PubMed ID: 18787978 [TBL] [Abstract][Full Text] [Related]
2. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. Anil S; Hashem M; Vellappally S; Patil S; Bandara HM; Samaranayake LP Mycopathologia; 2014 Oct; 178(3-4):207-15. PubMed ID: 25142726 [TBL] [Abstract][Full Text] [Related]
3. Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus. Pereira Tdos S; Silva Alves Jde F; Gomes CC; Rocha do Nascimento A; Stoianoff MA; Gomez RS J Oral Pathol Med; 2014 Sep; 43(8):570-5. PubMed ID: 25320748 [TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related]
5. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis. Anil S; Samaranayake LP Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro. Dorocka-Bobkowska B; Konopka K Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
9. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health. Brilhante RSN; de Alencar LP; Cordeiro RA; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Lima DT; Paiva MAN; Monteiro AJ; Alves ND; Franco de Oliveira M; Sidrim JJC; Rocha MFG; Bandeira TJPG; Rodrigues TJS J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027 [TBL] [Abstract][Full Text] [Related]
10. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783 [TBL] [Abstract][Full Text] [Related]
11. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Koga-Ito CY; Lyon JP; Vidotto V; de Resende MA Mycopathologia; 2006 Apr; 161(4):219-23. PubMed ID: 16552484 [TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility of Candida isolates at one institution. Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093 [TBL] [Abstract][Full Text] [Related]
13. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443 [TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization. Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636 [TBL] [Abstract][Full Text] [Related]
15. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida]. Zhao M; Zhou ZT Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371 [TBL] [Abstract][Full Text] [Related]
16. Dynamics of Mixed- Candida Species Biofilms in Response to Antifungals. Vipulanandan G; Herrera M; Wiederhold NP; Li X; Mintz J; Wickes BL; Kadosh D J Dent Res; 2018 Jan; 97(1):91-98. PubMed ID: 28850289 [TBL] [Abstract][Full Text] [Related]
17. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661 [TBL] [Abstract][Full Text] [Related]
19. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel. Samra Z; Yardeni M; Peled N; Bishara J Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856 [TBL] [Abstract][Full Text] [Related]
20. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection. Anil S; Ellepola AN; Samaranayake LP Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]